Patent ID: 7803776
Filing Date: 2010-09-28
Classification: A61K,A61P

Abstract:
1. A method for producing in an individual in need of treatment for allergic reactions of type I a more than additive to superadditive inhibition of the activation, proliferation, and DNA-synthesis and production of T H2 cytokines by, human T lymphocytes and mononuclear cells, comprising administering to the individual an effective amount of a composition comprising an inhibitor of dipeptidyl peptidase IV (DP IV) as well as of enzymes having the same substrate specificity (DP IV-analogous enzymatic activity) in combination with an inhibitor of alanyl-aminopeptidase (aminopeptidase N, APN) as well as of enzymes having the same substrate specificity (APN-analogous enzymatic activity).